| Jia, Xu; Shanmugam, Chandrakumar; Paluri, Ravi K et al. (2017) Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Oncotarget 8:20198-20212 |
| Council, Leona N; Shanmugam, Chandrakumar; Suswam, Esther A et al. (2016) Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas. J Dig Dis Hepatol 2016: |
| Bovell, Liselle C; Shanmugam, Chandrakumar; Putcha, Balananda-Dhurjati K et al. (2013) The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clin Cancer Res 19:3955-65 |
| Bovell, L C; Putcha, B D K; Samuel, T et al. (2013) Clinical implications of microRNAs in cancer. Biotech Histochem 88:388-96 |
| Vogtmann, Emily; Shanmugam, Chandrakumar; Katkoori, Venkat R et al. (2013) Socioeconomic status, p53 abnormalities, and colorectal cancer. J Gastrointest Oncol 4:40-4 |
| Katkoori, Venkat R; Shanmugam, Chandrakumar; Jia, Xu et al. (2012) Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas. PLoS One 7:e30020 |
| Shanmugam, Chandrakumar; Hines, Robert B; Jhala, Nirag C et al. (2011) Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer. J Hematol Oncol 4:25 |
| Katkoori, Venkat R; Suarez-Cuervo, Catalina; Shanmugam, Chandrakumar et al. (2010) Bax expression is a candidate prognostic and predictive marker of colorectal cancer. J Gastrointest Oncol 1:76-89 |
| Manne, Upender; Shanmugam, Chandrakumar; Bovell, Liselle et al. (2010) miRNAs as biomarkers for management of patients with colorectal cancer. Biomark Med 4:761-70 |
| Anderson, Billie; Hardin, J Michael; Alexander, Dominik D et al. (2010) Comparison of the predictive qualities of three prognostic models of colorectal cancer. Front Biosci (Elite Ed) 2:849-56 |
Showing the most recent 10 out of 26 publications
